Tag: opioids market size

  • Opioids Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities

    Opioids Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Are the Primary Drivers Supporting the Market Growth of theOpioids Market?

    The surge in the number of surgeries is anticipated to offer a major thrust to the expansion of the opioids market. Surgical procedures refer to medical reparative processes that demand incision-making with instruments, primarily undertaken in an operation theatre and frequently necessitating anesthetics or breathing support. Opioids are administered during these surgical procedures for easing pain and as adjuncts to anesthesia or primary anesthetic agents. For example, the Organization for Economic Co-operation and Development, based in France, reported in August 2023 that there was an 8.4% increase to 142,670 in cataract surgeries conducted in the Czech Republic in 2022, up from 131,612 procedures in 2021. Furthermore, laparoscopic repairs of inguinal hernia in Turkey saw a 35.2% spike, increasing from 18,739 procedures in 2021 to 25,348 in 2022. Consequently, the escalation in surgical procedures is projected to bolster the opioids market.

    Opioids Market Driver: Escalating Incidence of Chronic Illnesses Poised to Boost Opioids Market Growth

     

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

    #How Does the ProjectedOpioids Market Growth Compare Over the Forecast Period?

    The size of the opioids market has been consistently expanding in the past few years. It is projected to rise from $23.54 billion in 2024 to $24.22 billion in 2025, displaying a compound annual growth rate (CAGR) of 2.9%. The proliferation in the historical timeline can be credited to factors such as pain management, surgical procedures, palliative care, and regulatory environment.

    Expectations suggest that the opioids market will experience unvarying growth over the coming years, potentially escalating to $27.62 billion by 2029, increasing at a compound annual growth rate (CAGR) of 3.3%. The impending expansion during the forecast period could be a result of factors like non-cancer pain indications, changes in regulation, the advent of telemedicine and remote prescribing, and management of chronic pain. Key trends to note during this forecast period encompass strategies for opioid-sparing, medication-assisted treatment (MAT), mitigation of risk, and initiatives related to public health.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13021

    What Are the Latest Innovations Influencing theOpioids Market?

    Leading businesses in the opioid market are concentrating on the development of cutting-edge drug solutions to strengthen their market standing. The invention of new drugs provides potential treatment for various diseases, thereby enriching the healthcare and scientific sectors. Braeburn Pharmaceuticals Inc., a US-based company specializing in opioid addiction treatments, announced in May 2023 that the US Food and Drug Administration had approved its Brixadi (buprenorphine) extended-release injectable for subcutaneous use (under the skin) for treating moderate to severe opioid use disorder (OUD). This stands as the first and only subcutaneous injection meant for moderate to severe OUD patients on a weekly and monthly basis. It is also the first buprenorphine injectable that uses FluidCrystal Injection Depot Technology. Patients who are on oral buprenorphine-based medications can switch to equivalent doses of this new treatment under correct prescription guidance.

    Who Are the Major Industry Players Accelerating Growth in theOpioids Market?

    Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca PLC, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals PLC, Alkermes PLC, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

    Which Primary Segments of the Opioids Market Are Driving Growth and Industry Transformations?

    The opioids market covered in this report is segmented –

    1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

    2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

    3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

    4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

    5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

    Subsegments:

    1) By Methadone: Methadone Tablets, Methadone Oral Solution

    2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

    3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

    4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

    5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

    6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

    7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=13021&type=smp

    Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theOpioids Market?# Market?

    North America was the largest region in the opioids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in opioids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Browse Through More Reports Similar to the Global Opioids Market 2025, By The Business Research Company:

    E-Pharmacy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/e-pharmacy-global-market-report

    Generic Pharmaceuticals Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

    Pharmaceutical Drug Delivery Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • In-Depth Insights into the Opioids Market: Growth, Trends, and Opportunities for 2025-2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What fueled the previous growth in the opioids market?

    The opioids market has grown steadily, expected to increase from $23.54 billion in 2024 to $24.22 billion in 2025, with a CAGR of 2.9%. Factors contributing to this growth include their use in pain management, surgical procedures, palliative care, and regulatory policies.

    What will be the opioids market size in the future?

    The opioids market is anticipated to see steady growth, reaching $27.62 billion by 2029 with a CAGR of 3.3%. Growth factors include increased demand for non-cancer pain management, regulatory changes, the rise of telemedicine, and chronic pain treatments. Key trends include opioid-sparing strategies, medication-assisted treatments, risk mitigation, and public health initiatives.

    Get your opioids market report here!

    https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

    What main drivers are fueling expansion in the opioids market?

    Rising healthcare expenditures are anticipated to accelerate the growth of the ophthalmic lasers market. Healthcare spending includes costs related to medical services, public health initiatives, and pharmaceuticals, and is influenced by aging populations, medical advancements, and chronic disease prevalence. Increased healthcare funding supports the adoption of advanced laser technologies for precision eye care. According to Health Affairs, the U.S. national healthcare expenditure is projected to rise from $4,799.3 billion in 2023 to $5,048.8 billion in 2024, marking an increase of $249.5 billion. This rise in healthcare spending is contributing to the expansion of the ophthalmic laser market.

    What key areas define the segmentation of the global opioids market?

    The opioids market covered in this report is segmented –

    1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

    2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

    3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

    4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

    5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

    Subsegments:

    1) By Methadone: Methadone Tablets, Methadone Oral Solution

    2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

    3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

    4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

    5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

    6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

    7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

    Who are the dominant players expanding their reach in the opioids market?

    Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca PLC, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals PLC, Alkermes PLC, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

    How are evolving market trends shaping opioids Strategies?

    Leading firms in the opioid market are prioritizing the innovation of sophisticated drug solutions to strengthen their market presence. The development of novel drugs can potentially enable the treatment of illnesses, and contribute towards the enhancement of healthcare and scientific comprehension. In May 2023, Braeburn Pharmaceuticals Inc., an American company providing solutions for opioid addiction treatment, announced that the US Food and Drug Administration approved Brixadi (buprenorphine) extended-release injectable for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD). It stands as the first and only weekly and monthly subcutaneous injection for moderate to severe OUD, and the first injectable buprenorphine medication utilizing FluidCrystal Injection Depot Technology. If the prescriptive guidance is properly adhered to, patients taking oral buprenorphine-based medicines can transition to equivalent dosages.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13021

    Which regions are emerging as leaders in the opioids market?

    North America was the largest region in the opioids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in opioids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    Browse Through More Similar Reports By The Business Research Company:

    E-Pharmacy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/e-pharmacy-global-market-report

    Generic Pharmaceuticals Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

    Pharmaceutical Drug Delivery Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Exploring Key Insights of the Opioids Market: Growth Prospects, Emerging Trends, and Opportunities

    Exploring Key Insights of the Opioids Market: Growth Prospects, Emerging Trends, and Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How Rapidly is the Opioids Market Expected to Expand Between 2025 and 2034 Based on Current Trends?

    In recent times, the size of the opioids market has seen a consistent increase. It’s projected to expand from $23.54 billion in 2024 to $24.22 billion in come 2025, marking a compound annual growth rate (CAGR) of 2.9%. This upward trend during the historic period is largely owed to factors like pain management, surgical procedures, palliative care, and the regulatory landscape.

    In the coming years, the market of opioids is projected to experience consistent expansion. The market value is anticipated to reach $27.62 billion in 2029, with a compound annual growth rate (CAGR) of 3.3%. Factors contributing to the predicted growth during this forecast period include non-cancer pain indications, regulatory alterations, the rise of telemedicine and remote prescribing, and chronic pain management. Key trends to observe during this forecast period are strategies to spare opioid usage, medication-assisted treatment (mat), risk reduction measures, and public health initiatives.

    What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Opioids Market?

    The growth in the number of surgical procedures is projected to fuel the expansion of the opioids market. Surgical procedures involve medical treatment that requires incisions with instruments, usually performed in an operating theatre and often requiring anaesthetics or ventilator support. Opioids are utilised during these procedures for pain management and as supplementary or primary anaesthetic substances. For example, the Organization for Economic Co-operation and Development reported an 8.4% increase in cataract surgeries in the Czech Republic in August 2023. The number grew from 131,612 procedures in 2021 to 142,670 procedures in 2022. Similarly, Turkey saw a 35.2% increase in laparoscopic inguinal hernia surgeries, from 18,739 in 2021 to 25,348 in 2022. These increasing surgical procedures, therefore, contribute to the growth of the opioid market. The rise in chronic diseases is also expected to be a growth driver in the opioids market. Chronic diseases or non-communicable diseases (NCDs) are slow-progressing, long-term medical conditions that typically persist for an extended period. Because chronic diseases often last for years or potentially a lifetime, there is an increased demand for opioids for managing chronic pain. For instance, the World Health Organization reported in September 2022 that chronic diseases caused 41 million deaths annually, which is 74% of deaths worldwide. Among these, 17.9 million were due to cardiovascular diseases, 9.3 million to cancer, 4.1 million to chronic respiratory diseases and 2.0 million to diabetes. As such, the growing prevalence of chronic diseases is propelling the growth of the opioid market.

    Explore Comprehensive Insights Into The Global Opioids Market With A Free Sample Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

    Which Key Players Are Shaping the Future of the Opioids Market?

    Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca PLC, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals PLC, Alkermes PLC, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

    How Are the Latest Trends Influencing the Growth of the Opioids Market?

    Leading firms in the opioid market are prioritizing the innovation of sophisticated drug solutions to strengthen their market presence. The development of novel drugs can potentially enable the treatment of illnesses, and contribute towards the enhancement of healthcare and scientific comprehension. In May 2023, Braeburn Pharmaceuticals Inc., an American company providing solutions for opioid addiction treatment, announced that the US Food and Drug Administration approved Brixadi (buprenorphine) extended-release injectable for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD). It stands as the first and only weekly and monthly subcutaneous injection for moderate to severe OUD, and the first injectable buprenorphine medication utilizing FluidCrystal Injection Depot Technology. If the prescriptive guidance is properly adhered to, patients taking oral buprenorphine-based medicines can transition to equivalent dosages.

    Secure Your Global Opioids Market Report Now for Fast and Efficient Delivery!

    https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

    Which Segments of the Opioids Market Hold the Most Potential for Future Development?

    The opioids market covered in this report is segmented –

    1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

    2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

    3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

    4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

    5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

    Subsegments:

    1) By Methadone: Methadone Tablets, Methadone Oral Solution

    2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

    3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

    4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

    5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

    6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

    7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

    What Regions Are At the Forefront of Opioids Market Expansion?

    North America was the largest region in the opioids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in opioids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    How Is the Opioids Market Classified and Defined in Market Analysis?

    Opioids refer to a group of powerful medications extracted or manufactured from the opium poppy plant that works on the neurological system to alleviate the effects of pain. They are extremely useful in the treatment of moderate to severe pain, such as post-surgery pain, cancer-related pain, or chronic pain disorders, as well as coughing and diarrhea.

    Browse Through More Similar Reports By The Business Research Company:

    E-Pharmacy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/e-pharmacy-global-market-report

    Generic Pharmaceuticals Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

    Pharmaceutical Drug Delivery Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: